AASLD: Treating Before Transplant Cuts HCV Recurrence (CME/CE)

You can't request more than 20 challenges without solving them. Your previous challenges were flushed.
Courtesy MedPage Today Surgery  Fri, 11/06/2009 - 08:34

BOSTON (MedPage Today) -- In patients with advanced liver disease related to hepatitis C, a course of pegylated interferon and ribavirin (Rebetol) before liver transplant may help them avoid recurrence of infection, a researcher said here.

Tags:

 

More related items

AASLD: Oral HCV Combo Yields Rapid Response (CME/CE)
SAN FRANCISCO (MedPage Today) -- A combination of two investigational antiviral drugs with different mechanisms of action against hepatitis C virus yielded quick and persistent responses in...

AASLD: New HCV Drug Promising, Cuts Out Interferon...
SAN FRANCISCO (MedPage Today) -- Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by -- pegylated interferon-alpha.

HIV No Barrier to Liver Transplant
TORONTO (MedPage Today) -- People with HIV do just as well as others after a liver transplant -- as long as they don't have hepatitis C as well, researchers said in Copenhagen.

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com